Gene therapy treatment for blood disease approved in Europe

Genetically modification of humans has been been approved for the first time in Europe. Swiss-based biotech company Crispr Therapeutics hope to find a way of curing blood disease beta thalassaemia.

China has approved similar gene therapy trials. A trial into treating cancer patients is under way in the USA.